Sanatorio Parque (Site 0201)

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Kidney cancer1 trial
• Lung cancer1 trial

Phase

• Phase 32 trials

Status

• Recruiting2 trials

Lead sponsor

• Merck Sharp & Dohme LLC2 trials

Running trials

• Recruiting

  A Clinical Study of Belzutifan and Zanzalintinib in People With Recurrent Kidney Cancer Following Adjuvant Therapy (MK-6482-033)

  NCT07227402· Phase 3· Merck Sharp & Dohme LLC· Source

  Contact: Study Coordinator

• Recruiting

  Pembrolizumab With or Without Maintenance Sacituzumab Tirumotecan (Sac-TMT; MK-2870) in Metastatic Squamous Non-small Cell Lung Cancer (NSCLC) [MK-2870-023]

  NCT06422143· Phase 3· Merck Sharp & Dohme LLC· Source

  Contact: Study Coordinator

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Kidney cancer1 recruiting
• Lung cancer1 recruiting